Plant derived inhibitors of bacterial efflux pumps: an update

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Phytochemistry Reviews

• Publication date

  2015-09-08

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s11101-015-9436-y
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Antimycobacterial activity of diospyrin and its derivatives against Mycobacterium aurum

  2015cited by this paper
• Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid‐ and Multidrug‐resistant Escherichia coli

  2015cited by this paper
• Polyphenolic Extract from Maple Syrup Potentiates Antibiotic Susceptibility and Reduces Biofilm Formation of Pathogenic Bacteria

  2015cited by this paper
• Combating against methicillin‐resistant Staphylococcus aureus – two fatty acids from Purslane (Portulaca oleracea L.) exhibit synergistic effects with erythromycin

  2015cited by this paper
• Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.

  2015influential reference
• A new antibiotic kills pathogens without detectable resistance

  2015cited by this paper
• Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)-5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump.

  2015cited by this paper
• SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.

  2015cited by this paper
• Antibiotic Resistance Modulation and Modes of Action of (-)-α-Pinene in Campylobacter jejuni

  2015cited by this paper
• The inhibition the Tet(K) efflux pump of tetracycline resistant Staphylococcus epidermidis by essential oils from three Salvia species

  2015cited by this paper
• Antimicrobial and efflux pumps inhibitory activities of Eucalyptus grandis essential oil against respiratory tract infectious bacteria

  2015cited by this paper
• Enhancing activity of antibiotics against Staphylococcus aureus: Zanthoxylum capense constituents and derivatives.

  2015influential reference
• Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model

  2014cited by this paper
• Resveratrol against Arcobacter butzleri and Arcobacter cryaerophilus: activity and effect on cellular functions.

  2014cited by this paper
• Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.

  2014cited by this paper
• Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening and In Vitro Validation

  2014influential reference
• Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2.

  2014cited by this paper
• Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them

  2014influential reference
• Antimicrobial and Resistance Modulatory Activity of Alpinia katsumadai Seed Phenolic Extract, Essential Oil and Post-Distillation Extract

  2014cited by this paper
• Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline

  2014cited by this paper
• Evaluation of cell membrane integrity as a potential antimicrobial target for plant products

  2014cited by this paper
• The Efflux Pump Inhibitor Timcodar Improves the Potency of Antimycobacterial Agents

  2014cited by this paper
• Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.

  2014influential reference
• Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid‐Resistant Escherichia coli

  2013cited by this paper
• 7-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc² 155.

  2013cited by this paper
• A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus.

  2013influential reference
• NorA efflux pump inhibitory activity of coumarins from Mesua ferrea.

  2013cited by this paper
• Sarothrin from Alkanna orientalis Is an Antimicrobial Agent and Efflux Pump Inhibitor

  2013influential reference
• Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.

  2012cited by this paper
• Adaptive and Mutational Resistance: Role of Porins and Efflux Pumps in Drug Resistance

  2012influential reference
• Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors.

  2012cited by this paper
• Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.

  2012cited by this paper
• Carnosic acid is an efflux pumps modulator by dissipation of the membrane potential in Enterococcus faecalis and Staphylococcus aureus

  2012cited by this paper
• Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.

  2012cited by this paper
• Natural products as sources of new drugs over the 30 years from 1981 to 2010.

  2012influential reference
• Plants as sources of new antimicrobials and resistance-modifying agents.

  2012cited by this paper
• Plant-derived antimicrobial compounds: alternatives to antibiotics.

  2012cited by this paper
• Phenylpropanoids of Alpinia galanga as efflux pump inhibitors in Mycobacterium smegmatis mc² 155.

  2012cited by this paper
• The effect of clove extract on the minimum inhibitory concentration of ciprofloxacin in fluoroquinolone resistant clinical isolates of Staphylococcus aureus

  2012cited by this paper
• Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus.

  2011cited by this paper
• Medicinal plant extracts with efflux inhibitory activity against Gram-negative bacteria.

  2011cited by this paper
• Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now.

  2011cited by this paper
• Inhibition of efflux pumps in methicillin-resistant Staphylococcus aureus and Enterococcus faecalis resistant strains by triterpenoids from Momordica balsamina.

  2011cited by this paper
• Synergistic interactions of saponins and monoterpenes in HeLa cells, Cos7 cells and in erythrocytes.

  2011cited by this paper
• Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

  2009cited by this paper
• New potent P-glycoprotein modulators with the cucurbitane scaffold and their synergistic interaction with doxorubicin on resistant cancer cells.

  2009cited by this paper
• Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE.

  2008cited by this paper
• The Efflux Pump Inhibitor Reserpine Selects Multidrug-Resistant Streptococcus pneumoniae Strains That Overexpress the ABC Transporters PatA and PatB

  2008cited by this paper
• Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis.

  2008cited by this paper
• Bacterial efflux pump inhibitors from natural sources.

  2007cited by this paper
• Natural products as sources of new drugs over the last 25 years.

  2007cited by this paper
• MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate.

  2007cited by this paper
• Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

  2006cited by this paper
• Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)

  2006cited by this paper
• Emergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy

  2005cited by this paper
• In Vitro Pharmacodynamics of Amphotericin B, Itraconazole, and Voriconazole against Aspergillus, Fusarium, and Scedosporium spp

  2005cited by this paper
• Inhibition of P-Glycoprotein Function and Expression by Kaempferol and Quercetin

  2005cited by this paper
• Antibacterial and resistance modifying activity of Rosmarinus officinalis.

  2004cited by this paper
• MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety.

  2004cited by this paper
• Induction of apoptosis in human cancer cell lines by diospyrin, a plant-derived bisnaphthoquinonoid, and its synthetic derivatives.

  2002cited by this paper
• Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy

  2001cited by this paper
• Linezolid resistance in a clinical isolate of Staphylococcus aureus.

  2001cited by this paper
• Molecular Properties of Bacterial Multidrug Transporters

  2000influential reference
• Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic.

  1980cited by this paper
• Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.

  1980cited by this paper
• Mechanism of cardiac glycoside inhibition of the (Na+-K+)-dependent ATPase from cardiac tissue.

  1968cited by this paper
• Staphylococcus aureus

  1948cited by this paper
• Send Orders of Reprints at Reprints@benthamscience.net Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation

  year unknowncited by this paper

• In-vitro and in-silico anti-staphylococcal effects of the Mayan medicinal plant Krugiodendron ferreum (Vahl) Urb. (X-chintok): Disarming its resistance mechanisms and virulence factors.

  2026cites this paper
• Molecular insights into the inhibition of MexCD-OprJ efflux pumps by menthol and thymol in Pseudomonas aeruginosa

  2025cites this paper
• Evaluation of the Activity of Amino Chalcone Against Staphylococcus Strains Harboring Efflux Pumps

  2025cites this paper
• Phytochemical profiling and bioactivity validation of Moringa oleifera leaves: Antimicrobial, antidiarrheal, analgesic, and in silico insights

  2025cites this paper
• Human vaginal Lactobacillus Jensenii -derived (-)-Terpinen-4-ol restores antibiotic sensitivity by inhibiting efflux pumps in drug resistant E. coli and K. pneumoniae

  2025cites this paper
• Unraveling the Intricate Roles of Plant Secondary Metabolites in Mitigating Bacterial Multidrug Resistance: Challenges and Prospects.

  2025cites this paper
• Anti-staphylococcal activity, antibiotic-resistance modulation effects and action of Harungana madagascariensis (Hypericaceae) fruit extracts on the antioxidant system of multidrug-resistant Staphylococcus aureus

  2025cites this paper
• Zataria multiflora essential oil: a potent agent with antibacterial, anti-NorA efflux pump and anti-biofilm activity against ciprofloxacin-resistant Staphylococcus aureus isolates from bovine mastitis

  2025cites this paper
• Plant-derived efflux pump inhibitors potentiate Chlorin e6-based antimicrobial photodynamic therapy against Bacillus cereus and Escherichia coli.

  2025cites this paper
• Efflux pump inhibitors from plant compounds: A new strategy to modulate bacterial growth and morphology

  2025cites this paper
• Synthesis, Characterization, and Antioxidant Activity Evaluation of New N-Methyl Substituted Thiazole-Derived Polyphenolic Compounds

  2025cites this paper
• Phytotherapeutic potential against MRSA: mechanisms, synergy, and therapeutic prospects

  2024cites this paper
• Antimicrobials from endophytes as novel therapeutics to counter drug-resistant pathogens

  2024cites this paper
• Phytochemical Composition, Antibacterial, and Antibiotic-Resistance Modulatory Activity of Extracts of Lippia multiflora Moldenke, Terminalia mollis M. A. Lawson, and Cinchona officinalis L. Against Multidrug-Resistant Pseudomonas aeruginosa

  2024cites this paper
• Screening and Evaluation of Potential Efflux Pump Inhibitors with a Seaweed Compound Diphenylmethane-Scaffold against Drug-Resistant Escherichia coli

  2024cites this paper
• The culmination of multidrug-resistant efflux pumps vs. meager antibiotic arsenal era: Urgent need for an improved new generation of EPIs

  2023cites this paper
• Antibacterial potential of an ethnic probiotic containing food, Akhuni/Axone and its chemical characterization

  2023cites this paper
• Exploring the potential of phytochemicals and nanomaterial: a boon to antimicrobial treatment

  2023cites this paper
• Action of crude ethanol extract of Hymenaea martiana leaf, gallic acid, and polypyrrole (PPy) against Aeromonas hydrophila

  2023cites this paper
• EFFLUX PUMPS AS A PHARMACOLOGICAL TARGET TO COMBAT ANTIBIOTIC RESISTANCE

  2023cites this paper
• Secondary metabolites of plants and their possible role in the "age of superbugs".

  2023cites this paper
• The Art of War with Pseudomonas aeruginosa: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy

  2023cites this paper
• Phenolic Compound Ethyl 3,4-Dihydroxybenzoate Retards Drug Efflux and Potentiates Antibiotic Activity

  2022cites this paper
• Antioxidant capacity and combinatorial antimicrobial effects of Nordostachys jatamansi essential oil with conventional antibiotics against some drug resistant bacteria

  2022cites this paper
• Antibacterial potential of chalcones and its derivatives against Staphylococcus aureus

  2022cites this paper
• Terpenes as bacterial efflux pump inhibitors: A systematic review

  2022cites this paper
• Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia coli

  2022cites this paper
• Bacterial Multidrug Efflux Pumps at the Frontline of Antimicrobial Resistance: An Overview

  2022cites this paper
• Plant Essential Oils for Combating Antimicrobial Resistance via Re-potentiating the Fading Antibiotic Arsenal

  2022cites this paper
• In silico screening and in vitro validation of phytocompounds as multidrug efflux pump inhibitor against E. coli

  2022influential citation
• Antimicrobial Products from Plant Biodiversity

  2021cites this paper
• Enhancement of the antibiotic activity by quercetin against Staphylococcus aureus efflux pumps

  2021cites this paper
• Plant synthetic biology for producing potent phyto-antimicrobials to combat antimicrobial resistance.

  2021cites this paper
• In Silico Approach for Phytocompound-Based Drug Designing to Fight Efflux Pump-Mediated Multidrug-Resistant Mycobacterium tuberculosis

  2021cites this paper
• Embelin-loaded chitosan gold nanoparticles interact synergistically with ciprofloxacin by inhibiting efflux pumps in multidrug-resistant Pseudomonas aeruginosa and Escherichia coli.

  2021cites this paper
• Contemporary Insights on Antibacterial and Pharmacological Importance of Cichorium intybus: A Compendious Review

  2021cites this paper
• The Role of Essential Oils in the Inhibition of Efflux Pumps and Reversion of Bacterial Resistance to Antimicrobials

  2021cites this paper
• Role of medicinal plants from North Western Himalayas as an efflux pump inhibitor against MDR AcrAB-TolC Salmonella enterica serovar typhimurium: In vitro and In silico studies.

  2021cites this paper
• Delineating the role of phytocompounds against anti-bacterial drug resistance–An update

  2021cites this paper
• Flavonoids as Inhibitors of Bacterial Efflux Pumps

  2021cites this paper
• Recent advances in tackling microbial multidrug resistance with essential oils: combinatorial and nano-based strategies

  2020cites this paper
• Proteomic interrogation of antibiotic resistance and persistence in Escherichia coli – progress and potential for medical research

  2020influential citation
• Plant Secondary Metabolites in the Battle of Drugs and Drug-Resistant Bacteria: New Heroes or Worse Clones of Antibiotics?

  2020cites this paper
• Palladium-catalysed synthesis of arylnaphthoquinones as antiprotozoal and antimycobacterial agents.

  2020cites this paper
• The Antimicrobial Activity and Cellular Pathways Targeted By p-anisaldehyde and Epigallocatechin Gallate in the Opportunistic Human Pathogen Pseudomonas aeruginosa

  2020cites this paper
• In Vitro Antimicrobial Activity of Piper retrofractum Fruit Extracts against Microbial Pathogens Causing Infections in Human and Animals

  2020cites this paper
• Lavender essential oil induces oxidative stress which modifies the bacterial membrane permeability of carbapenemase producing Klebsiella pneumoniae

  2020cites this paper
• Natural Antimicrobial Agents

  2020cites this paper
• Resistance modulatory and efflux-inhibitory activities of capsaicinoids and capsinoids.

  2019cites this paper
• An efflux inhibitor of the MacAB pump in Salmonella enterica serovar Typhimurium

  2019cites this paper
• Antimicrobial Activity of, and Cellular Pathways Targeted by, p-Anisaldehyde and Epigallocatechin Gallate in the Opportunistic Human Pathogen Pseudomonas aeruginosa

  2019cites this paper
• Study on Multi Drug Resistant Opportunistic Pathogens Obtained from Clinical Settings of Tamil Nadu for Developing Novel Alternative Therapeutics

  2019cites this paper
• The alarming antimicrobial resistance in ESKAPEE pathogens: Can essential oils come to the rescue?

  2019cites this paper
• The Importance of RND-type Efflux Pumps in the Interactions of Pseudomonas aeruginosa with 4-Methoxybenzaldehyde

  2019influential citation
• Repurposing bioactive aporphine alkaloids as efflux pump inhibitors.

  2019cites this paper
• Reversal of multidrug resistance by amphiphilic morning glory resin glycosides in bacterial pathogens and human cancer cells

  2019cites this paper
• Identifying Natural Inhibitors of Bacterial Efflux Pumps Honors Thesis

  2019influential citation
• Mechanisms Efflux Pumps of Acinetobacter baumannii (MDR): Increasing Resistance to Antibiotics

  2019cites this paper
• Brown and Red Seaweeds Serve as Potential Efflux Pump Inhibitors for Drug-Resistant Escherichia coli

  2019cites this paper
• Plant essential oils as fish diet additives: benefits on fish health and stability in feed

  2018cites this paper
• Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance

  2018cites this paper
• Steroidal alkaloids and conessine from the medicinal plant Holarrhena antidysenterica restore antibiotic efficacy in a Galleria mellonella model of multidrug-resistant Pseudomonas aeruginosa infection

  2018cites this paper
• Methods of blocking efflux pump activity in Escherichia coli

  2018cites this paper
• Antimicrobial Compounds of Plant Origin as Efflux Pump Inhibitors: New Avenues for Controlling Multidrug Resistant Pathogens

  2018cites this paper
• Novel antibacterial modalities against methicillin resistant Staphylococcus aureus derived from plants

  2018cites this paper
• Antimicrobial Natural Products Against Campylobacter

  2018cites this paper
• The Potential of Systems Biology to Discover Antibacterial Mechanisms of Plant Phenolics

  2017cites this paper
• Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3‐Phenyl‐1,4‐benzothiazine Analogues

  2017cites this paper
• New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria

  2017cites this paper
• Antibacterial screening of Juncaceae species native to the Carpathian Basin against resistant strains and LC-MS investigation of phenanthrenes responsible for the effect.

  2016cites this paper
• Synergism between antibiotics and plant extracts or essential oils with efflux pump inhibitory activity in coping with multidrug-resistant staphylococci

  2016cites this paper
• AS A

  year unknowncites this paper